Multimodal treatment including standard chemotherapy with vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for the Ewing sarcoma family of tumors in Japan: Results of the Japan Ewing Sarcoma Study 04

Multimodal treatment including standard chemotherapy with vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for the Ewing sarcoma family of tumors in Japan: Results of the Japan Ewing Sarcoma Study 04

Background The survival rate in patients with Ewing sarcoma family of tumors (ESFT) in Japan was reported to be 

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Pediatric blood & cancer 2020-05, Vol.67 (5), p.e28194-n/a
Hauptverfasser: Chin, Motoaki, Yokoyama, Ryohei, Sumi, Minako, Okita, Hajime, Kawai, Akira, Hosono, Ako, Koga, Yuhki, Sano, Hideki, Watanabe, Hiroyoshi, Ozaki, Toshifumi, Mugishima, Hideo
Format: Artikel
Sprache:eng
Schlagworte:
Acute lymphoblastic leukemia
Chemotherapy
Cyclophosphamide
Doxorubicin
Etoposide
Ewing sarcoma family of tumors
Ewing's sarcoma
Ewings sarcoma
Hematology
Ifosfamide
Lymphatic leukemia
Medical prognosis
multimodal treatment
Myelodysplastic syndrome
Oncology
Osteosarcoma
Patients
Pediatrics
Prognosis
progression‐free survival secondary malignancies
Radiation therapy
Surgery
Survival
The Japan Ewing Sarcoma Study Group (JESS)
Tumors
Vincristine
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background The survival rate in patients with Ewing sarcoma family of tumors (ESFT) in Japan was reported to be 
ISSN:1545-5009
1545-5017
DOI:10.1002/pbc.28194